Medicine Description paclitaxel-actavis 30mg
Paclitaxel Actavis is a medication that functions by inhibiting the depolymerization of microtubules during cell division. This action stabilizes the microtubule structure, preventing the normal breakdown of microtubules required for mitosis. By interfering with the dynamics of the microtubule structure, paclitaxel disrupts the mitotic spindle formation, ultimately halting cell division and promoting programmed cell death (apoptosis) in cancerous cells. This mechanism of action is particularly effective against rapidly dividing cells, such as those found in various cancers.
Indications and Uses of Paclitaxel Actavis
- Initial treatment of advanced ovarian carcinoma in combination with other approved chemotherapeutic agents.
- Palliative treatment of recurrent ovarian carcinoma after prior chemotherapy.
- Treatment of breast cancer, including metastatic disease.
- Non-small cell lung cancer (in combination with cisplatin).
- Kaposi's sarcoma in patients with AIDS (in combination with other agents).
Side Effects of Paclitaxel Actavis
- Nausea and vomiting.
- Hair loss (alopecia).
- Bone marrow suppression, including neutropenia, anemia, and thrombocytopenia.
- Peripheral neuropathy, which may present as numbness or tingling.
- Fatigue and weakness.
- Allergic reactions such as rash or itching.
- Abdominal pain and diarrhea.
Storage and Handling
Store Paclitaxel Actavis at room temperature, away from light and moisture. Ensure the medication is kept in its original packaging until use. Do not freeze. Keep it out of reach of children and pets.
Patient Advice and Precautions
Patients should be monitored closely for signs of allergic reactions during and after administration. Regular blood tests may be required to assess blood cell counts due to the risk of bone marrow suppression. It is important to maintain hydration and report any unusual symptoms immediately. Patients should also be counseled on the potential for hair loss and strategies to cope with this side effect.